Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Tumorigenesis driven by the BRAFV600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion.
bioRxiv [Preprint]. 2024 Apr 20:2023.11.21.568071. doi: 10.1101/2023.11.21.568071.
bioRxiv. 2024.
PMID: 38659913
Free PMC article.
Preprint.
RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling.
Yao Z, Gao Y, Su W, Yaeger R, Tao J, Na N, Zhang Y, Zhang C, Rymar A, Tao A, Timaul NM, Mcgriskin R, Outmezguine NA, Zhao H, Chang Q, Qeriqi B, Barbacid M, de Stanchina E, Hyman DM, Bollag G, Rosen N.
Yao Z, et al. Among authors: timaul nm.
Nat Med. 2019 Feb;25(2):284-291. doi: 10.1038/s41591-018-0274-5. Epub 2018 Dec 17.
Nat Med. 2019.
PMID: 30559419
Free PMC article.
Item in Clipboard
The microtubule-stabilizing agents epothilones A and B and their desoxy-derivatives induce mitotic arrest and apoptosis in human prostate cancer cells.
Sepp-Lorenzino L, Balog A, Su DS, Meng D, Timaul N, Scher HI, Danishefsky SJ, Rosen N.
Sepp-Lorenzino L, et al.
Prostate Cancer Prostatic Dis. 1999 Jan;2(1):41-52. doi: 10.1038/sj.pcan.4500282.
Prostate Cancer Prostatic Dis. 1999.
PMID: 12496865
Item in Clipboard
Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.
Sepp-Lorenzino L, Tjaden G, Moasser MM, Timaul N, Ma Z, Kohl NE, Gibbs JB, Oliff A, Rosen N, Scher HI.
Sepp-Lorenzino L, et al.
Prostate Cancer Prostatic Dis. 2001;4(1):33-43. doi: 10.1038/sj.pcan.4500491.
Prostate Cancer Prostatic Dis. 2001.
PMID: 12497061
Item in Clipboard
Cite
Cite